Overview of Dr. Messersmith
Dr. Wells Messersmith is a medical oncologist in Aurora, CO and is affiliated with University of Colorado Hospital/University of Colorado Cancer Center. He received his medical degree from Harvard Medical School and has been in practice 17 years.
Office
12605 E 16th Ave
Aurora, CO 80045
Education & Training
- Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2001 - 2004
- Massachusetts General HospitalResidency, Internal Medicine, 1998 - 2001
- Harvard Medical SchoolClass of 1998
Certifications & Licensure![](https://directory.doximity.com/assets/icons/icon-help-e9f0b148a1e6d1f037dde9f26f025c36bd7c99fd4fe31fd76792996fa2aa5e66.svg)
- CO State Medical License 2007 - 2025
- MD State Medical License 2001 - 2015
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Testing the Combination of Anetumab Ravtansine With Either Nivolumab, Nivolumab and Ipilimumab, or Gemcitabine and Nivolumab in Advanced Pancreatic Cancer Start of enrollment: 2019 Dec 09
- TR1801-ADC in Patients With Tumors That Express c-Met Start of enrollment: 2019 Aug 14
Publications & Presentations
PubMed
- Adjuvant Chemotherapy After Resection of Localized Pancreatic Adenocarcinoma Following Preoperative FOLFIRINOX.Thomas F Stoop, Toshitaka Sugawara, Atsushi Oba, Isabel M Feld, Stijn van Roessel
JAMA Oncology. 2025-01-23 - Liver transplantation for colorectal cancer with liver metastases.Benjamin E Ueberroth, Michael Kriss, James R Burton Jr, Wells A Messersmith
The Oncologist. 2025-01-17 - CHD1L Inhibitor OTI-611 Synergizes with Chemotherapy to Enhance Antitumor Efficacy and Prolong Survival in Colorectal Cancer Mouse Models.Rita Sala, Hector Esquer, Timothy Kellett, Sophia Clune, Paul Awolade
International Journal of Molecular Sciences. 2024-12-07
Press Mentions
- Combination Slows Metastatic CRC Progression Better Than Single ImmunotherapyJanuary 27th, 2025
- Triple Therapy in Metastatic CRC with BRAF Mutations: The New Standard of Care?January 26th, 2025
- A University of Colorado Leader Gets a Voice on National Cancer Research PolicyJanuary 13th, 2025
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: